What is Compumation?
Compumation operates as a specialized provider of automation solutions, catering primarily to the rigorous demands of the pharmaceutical and food processing industries. With a legacy spanning over three decades, the firm functions as a critical partner for senior project engineers at Fortune 500 organizations. The company distinguishes itself by mitigating project risk, ensuring that complex automation upgrades and custom-built systems are delivered within strict budgetary and temporal constraints. By emphasizing early-stage project alignment, Compumation effectively navigates the technical hurdles inherent in large-scale industrial deployments, positioning itself as an essential service provider in the global manufacturing supply chain.
How much funding has Compumation raised?
Compumation has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Compumation
PPP
Public-Private Partnership
What's next for Compumation?
With the successful acquisition of this recent capital, Compumation is well-positioned to accelerate its growth trajectory and expand its footprint in the industrial automation landscape. The strategic focus will likely shift toward enhancing its custom-built automation capabilities and deepening its integration within the pharmaceutical and food manufacturing sectors. As the industry moves toward increased digitalization and smart factory adoption, Compumation is poised to leverage its deep domain expertise to capture additional market share. Future initiatives will likely prioritize the scaling of its engineering teams and the refinement of its project delivery frameworks to maintain its competitive edge in a rapidly evolving technological environment.
See full Compumation company page
